Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

X
Trial Profile

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Onapristone (Primary) ; Onapristone (Primary)
  • Indications Adenocarcinoma; Advanced breast cancer; Endometrial cancer; Ovarian cancer; Solid tumours; Uterine cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Arno Therapeutics
  • Most Recent Events

    • 01 Jul 2020 Results presented in the Context Therapeutics Media Release.
    • 27 Jun 2020 Results assessing safety of Onapristone Extended Release with emphasis on Hepatotoxicity published in the Drug Safety
    • 31 May 2019 Results of pooled analysis of this and NCT02049190 assessing safety of onapristone in patients with metastatic cancer, published in conjunction with 55th Annual Meeting of the American Society of Clinical Oncology (2019).
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top